ROTKREUZ, Switzerland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a top global medical device company known for creating and selling the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, has announced the introduction of Align X-ray Insights. This new software-based computer-aided detection solution will be available in European Union countries and the United Kingdom.
Align Technology is currently undervalued, with a price-to-free cash flow ratio of 15x and a weighted average cost of capital of 11.55%, even though it has a strong market presence and improved profit margins. The company's Invisalign product holds more than 90% of the clear aligners market, benefiting from high switching costs and the ability to set premium prices. Their financial results indicate healthy adjusted EBIT margins of 21.8%, and adjusted earnings per share are increasing, despite some sales growth challenges during the pandemic.
Align Technology has enhanced the iTero Lumina Solutions by adding restorative features to both the iTero Lumina intraoral scanner and the iTero Lumina Pro dental imaging system.
Align Technology (ALGN) shared its earnings report 30 days ago. What can we expect for the stock moving forward?
Doctors in the US who take part will be able to offer financing options for almost all of their patients. This means that patients can find financial help for their medical expenses.
US stocks performed well in 2024, but some companies did not take advantage of the positive mood last year. Nevertheless, a few of these companies are seen as having a good chance for recovery this year, according to analysts from Jefferies.
Giverny Capital Asset Management, LLC, an investment management firm, has just released its investor letter for the fourth quarter of 2024. You can download the letter here. While the portfolio performed well in the fourth quarter, it did not keep up with the S&P 500 Index, achieving a return of 0.78% compared to the S&P 500's 2.41%.
Align Technology (ALGN 0.75%), famous for its Invisalign clear aligners and digital dental solutions, shared its fourth-quarter 2024 results on February 5, 2025. The earnings report showed consistent performance despite challenges with currency and demand.
While the revenue and earnings per share (EPS) for Align Technology (ALGN) provide insight into its performance for the quarter ending December 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
Here's a quick look at how five MedTech stocks—BSX, HOLX, TECH, STE, and ALGN—are predicted to perform in their quarterly reports, which will be announced tomorrow.